Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The Kentucky-based insurance giant had owned a 40% stake in the hospice company, stemming from its 2021 acquisition of Kindred Healthcare. Humana said a “consortium of investors" is making the buy, but few details were revealed.
The buyout, announced last summer, drew the attention of federal regulators at the Federal Trade Commission, concerned that competition for ambulatory surgery services would be stifled by the merger. To appease the agency, Ascension has agreed to divest from some centers previously owned by Amsurg.
When Mayo Clinic and Microsoft announced last week that they’re partnering to develop a frontier AI model for healthcare, observers could see where Mayo’s expertise in advanced digital medicine would interest Microsoft. The Big Tech behemoth has not been coy about its healthcare ambitions.
Senate Bill 196 was signed into law by Gov. Ned Lamont a year after the state saw Prospect Medical Holdings, an investor-backed health system, fall into bankruptcy as investors extracted hundreds of millions of dollars in fees from its hospitals.
Dynocardia has now received nearly $5.1 million in funding from the NHLBI to help speed commercializing its wrist-worn monitor to avoid the need for invasive catheter BP monitoring.
Timothy Story, MD, said Ascension St. Vincent Medical Center damaged his career and reputation after they fired him without cause. After a three-and-a-half year legal trial, a jury in Indiana agreed.
The 18th annual rankings of the nation's best children's hospitals has been released by U.S. News & World Report, highlighting the top places for young patients to receive exceptional care in 2024-2025.
As 2024 winds down and the number of FDA-approved medical devices packing AI approaches 1,000—the agency had the tally at 950 as of August—the industry finds itself at a “critical inflection point.”